Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Envoy Medical, Inc. (COCH) had Revenue of $0.23M for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$0.23M
Net Income	$-27.97M
Cost of Goods Sold	$0.74M
Gross Profit	$-0.52M
Operating Expenses	$19.48M
Operating Income	$-19.26M
Non-Operating Income/Expense	$-1.54M
Pre-Tax Income	$-20.80M
Normalized Pre-Tax Income	$-20.80M
Income after Taxes	$-20.80M
Income from Continuous Operations	$-20.80M
Consolidated Net Income/Loss	$-20.80M
Normalized Income after Taxes	$-20.80M
EBIT	$-19.26M
EBITDA	$-18.04M
Weighted-Average Shares Outstanding (Basic)	18.79M
Weighted-Average Shares Outstanding (Diluted)	18.79M
Earnings per Share (EPS) (Basic)	$-1.49
Earnings per Share (EPS) (Diluted)	$-1.49
Balance Sheet Financials
Current Assets	$9.38M
Property, Plant, and Equipment	$1.27M
Long-Term Assets	$2.15M
Total Assets	$11.54M
Current Liabilities	$7.54M
Long-Term Debt	$18.72M
Long-Term Liabilities	$22.84M
Total Liabilities	$30.38M
Common Equity	$-18.84M
Tangible Shareholders Equity	$-18.84M
Shareholders Equity	$-18.84M
Common Shares Outstanding	21.33M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-17.95M
Cash Flow from Investing Activities	$-0.98M
Cash Flow from Financial Activities	$20.20M
Beginning Cash	$4.22M
End Cash	$5.48M
Increase/Decrease in Cash	$1.26M
Stock-Based Compensation	$0.56M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	$-2.45M
Fundamental Metrics & Ratios
Current Ratio	1.24
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-148.54
Debt to Equity Ratio	-0.99
Gross Margin	-229.78%
Operating Margin	-8558.22%
EBIT Margin	-8558.22%
EBITDA Margin	-8016.00%
Pre-Tax Profit Margin	-9242.22%
Profit Margin	-12432.44%
Free Cash Flow	$-18.93M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.02
Inventory Turnover	0.43
Receiveable Turnover	0.28
Days Sales in Receivables	1326.98
Return on Equity	110.37%
Return on Tangible Equity	110.37%
Return on Assets	-180.23%
Return on Investments	16504.04%
Book Value Per Share	$-0.88
Free Cash Flow per Share	$-1.01
Operating Cash Flow per Share	$-0.96

Data from Zacks Investment Research, Inc.